These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Pilot studies on the treatment of Mycobacterium avium complex lung disease--new macrolides and new quinolones. (1) Continuous positive cases (failure of the initial chemotherapy)]. Sakatani M. Kekkaku; 1996 Sep; 71(9):544-7. PubMed ID: 8999139 [No Abstract] [Full Text] [Related]
43. [Tuberculostatics]. Mordasini ER, Eulenberger J. Int Z Klin Pharmakol Ther Toxikol; 1971 Dec; 5(3):360-7. PubMed ID: 5004643 [No Abstract] [Full Text] [Related]
46. Clarithromycin with minocycline and clofazimine for Mycobacterium avium intracellulare complex lung disease in patients without the acquired immune deficiency syndrome. GETIM. Groupe d'Etude et de Traitement des Infections à Mycobactéries. Roussel G, Igual J. Int J Tuberc Lung Dis; 1998 Jun; 2(6):462-70. PubMed ID: 9626603 [Abstract] [Full Text] [Related]
47. [Evaluation of early results of treatment of pulmonary tuberculosis in Mycobacterium-positive patients. Comparison of the results of 3- and 4-drug treatment]. Martyniak K, Wyczółkowski M, Bochiński T. Pneumonol Pol; 1985 Apr; 53(4):195-201. PubMed ID: 3931056 [No Abstract] [Full Text] [Related]
51. [Chemotherapy in combination with the rapid intravenous administration of isoniazid in pulmonary tuberculosis]. Zbants AN, Tsurkan VP, Mustiatsé NA, Kurochkin SIa, Ustiian AI. Probl Tuberk; 1982 Dec; (12):45-8. PubMed ID: 7156122 [No Abstract] [Full Text] [Related]
52. [Recommendations for the therapy of tuberculosis]. Eule H, Ganguin HG. Z Erkr Atmungsorgane; 1984 Dec; 163(1):80-91. PubMed ID: 6485398 [No Abstract] [Full Text] [Related]
53. Drugs and regimens for preventive therapy against tuberculosis, disseminated Mycobacterium avium complex infection and leprosy. Ji B, Grosset JH. Int J Lepr Other Mycobact Dis; 1999 Dec; 67(4 Suppl):S45-55. PubMed ID: 10700937 [No Abstract] [Full Text] [Related]
54. [Important points in therapy of pulmonary tuberculosis and atypical mycobacterium respiratory infections]. Kawahara S. Nihon Naika Gakkai Zasshi; 1998 Feb 10; 87(2):297-302. PubMed ID: 9549327 [No Abstract] [Full Text] [Related]
55. [Effect of ultrasonic inhalation of antitubercular preparations on the hemodynamics of the greater and lesser circulations in tuberculosis patients]. Protsiuk RG, Zozulia AA. Vrach Delo; 1986 Nov 10; (11):19-22. PubMed ID: 3825035 [No Abstract] [Full Text] [Related]
58. [New cases of pulmonary tuberculosis treatment within DOTS strategy]. Zhangireev AA, Ismailov ShSh, Berikova EM. Probl Tuberk; 2000 Nov 10; (3):23-5. PubMed ID: 10900979 [Abstract] [Full Text] [Related]
59. [Early and late results of 6-month treatment of pulmonary tuberculosis with various drug combinations]. Rogowski J, Zierski M, Bek E, Snider DE, Long MW. Pneumonol Pol; 1982 Sep 10; 50(9):425-35. PubMed ID: 7163000 [No Abstract] [Full Text] [Related]
60. [Drug combinations and duration of the regimen at the initial treatment of tuberculosis]. Hara K. Kekkaku; 1983 Sep 10; 58(9):492-5. PubMed ID: 6663964 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]